The Drug Controller General of India (DCGI) has suspended the authorisation granted to Mumbai-based Entod Pharmaceuticals to manufacture and market its eye drops, citing unapproved claims made by the company regarding its effectiveness in reducing dependence on reading glasses for individuals with presbyopia.
Read MoreSubscribe to our newsletter to get updates on our latest news